Mü llerian-inhibiting substance (MIS) plays an essential role in mammalian male sexual development; thus, it is important to determine how the tightly regulated expression of the MIS gene is transcriptionally controlled. Transcription of eukaryotic genes is dependent on regulatory elements in the enhancer and one or both distinct elements in the core promoter: the TATA box, and the initiator (Inr) element. Because the human MIS gene does not contain a consensus TATA and has not been reported to contain an Inr element, we hypothesized that the initiator region of the core promoter was essential for promoter activity. Transient transfection assays were conducted using an immortalized Embryonic Day 14.5 male rat urogenital ridge cell line (CH34) that expresses low levels of MIS. These studies revealed that promoter activity is dependent on the region around the start site (Ϫ6 to ؉10) but not on the nonconsensus TATA region. Electrophoretic mobility shift assays demonstrated that the human MIS initiator sequence forms a specific DNA-protein complex with CH34 cell nuclear extract, HeLa cell nuclear extract, and purified TFII-I. This complex could be blocked or supershifted by the addition of antibodies directed against TFII-I. These data suggest that the human MIS gene contains a functional initiator that is specifically recognized by TFII-I.
INTRODUCTION
Müllerian-inhibiting substance (MIS), also known as anti-müllerian hormone, is a glycoprotein [1, 2] related to the transforming growth factor (TGF)-␤ family of growth and differentiation factors [3] . In male subjects, MIS is produced in Sertoli cells of the fetal and postnatal testis [4, 5] , and it causes regression of the embryonic müllerian duct, anlagen of the uterus, fallopian tubes, and upper vagina [6, 7] . In female subjects, MIS is produced by granulosa cells 1 Supported by NIH grant HD30812 to P.K.D. and in part by ACS grant RPG-98-104-01-TBE and NIH grant AI41147 to A.L.R., NIH grant HD08177 and a fellowship from ACS to T.R.C., NIH grant HD33462 to M.A.W., the Gerald Austen Surgical Research and Surdna GAR funds to N.M., and the M.G.H. Medical Discovery Award to C.M.H. after birth [8, 9] . During puberty, it blocks meiosis of oocytes from immature rat ovarian follicles in vitro [10, 11] . It can also inhibit the proliferation of certain established and primary human tumor cells both in vivo and in vitro [12] [13] [14] [15] [16] . The genes for human [17] , bovine [17] , rat [18] , and mouse [19] MIS have been isolated and the primary structure of the encoded proteins deduced [17, 20] . The present studies were undertaken to examine the relative roles of the core promoter elements and their mutual interactions in the tissue-specific promoter MIS.
Most protein-coding genes contain a TATA box that is required for accurate transcription initiation. However, the finding that some promoters lack a TATA box yet accurately initiate transcription led to the discovery of initiator (Inr) elements spanning the start site [21, 22] . The human MIS (hMIS) promoter lacks a consensus TATA element; therefore, we examined whether it had a functional Inr element. The sequence encompassing the hMIS start site [17, 23, 24] does not fit previously published initiator consensus sequences; however, when basal transcription directed by the wild-type core promoter was compared with the promoter in which the initiator site was mutated, the start site was found to be functionally necessary. Similar analysis of the nonconsensus TATA site showed that it was not required.
Initiator elements have been demonstrated to direct accurate transcription from heterologous [25, 26] as well as natural promoters [27, 28] , and their mutation or deletion can decrease or abolish transcription [29] . Initiator elements can also function synergistically with a TATA box element [28, 30, 31] . Several models have been advanced to describe how specific transcription is initiated through Inr elements. One model suggests that TATA-binding protein (TBP)-associated factors (TAFs) are capable of binding to Inr elements to direct transcription [32] [33] [34] . A second model suggests that Inr elements are directly recognized by RNA polymerase II [35] . A third proposes that initiatordependent transcription can be mediated by initiator-specific binding proteins such as TFII-I [36, 37] or YY1 [30] , which can substitute for TFIIA [38, 39] or TBP [40] , respectively. Gel shift analyses demonstrated that the hMIS Inr is recognized by the initiator-binding protein TFII-I, suggesting that hMIS core transcription may employ the third model for initiator-dependent transcription. Analysis of the sequences of several different functional Inr elements led to the definition of Py Py A ϩ1 N T/A Py Py as the consensus sequence [41] . However, several genes, including the human TGF␣ gene [42] , human chorionic somatomammotropin gene [43] , and now, the hMIS gene, have been identified that contain functional Inr elements that do not match the consensus initiator sequence. In fact, TFII-I has six helix-loop-helix (HLH) domains, which may allow it to recognize several independent DNA elements; thus, the hMIS Inr may be a novel TFII-I-binding element.
MATERIALS AND METHODS

Construction of Plasmids
The plasmid p-269/ϩ8,hMIS-luc was created by amplifying a region of the 5Ј-flanking sequence of the hMIS gene [17] . The fragment (from Ϫ269 to ϩ8 relative to the previously reported start site) was made by the polymerase chain reaction (PCR) using the primers NMI and NM2 as the 5Ј-and 3Ј-primers, respectively (Table 1) , which introduced HindIII sites 5Ј and 3Ј of the fragment. The fragment was subcloned into the HindIII site of the pA3 luciferase vector, pA3-luc [44] . Constructs containing mutations in the nonconsensus TATA region (from Ϫ28 to Ϫ23 relative to the start site) or the initiator region (from Ϫ22 to ϩ10) of the MIS promoter (Fig. 1A) , called p-269hMIS,TATAmutluc and p-269hMIS,Inrmut-luc, respectively, were created by PCR using primers NM1 as the 5Ј-primer and TATA mut or INR mut as the 3Ј-primer, respectively. For the construction of reporters containing the hMIS initiator (phMISInr-luc [also called hMIS,Ϫ22ϩ10-luc]), the adenovirus major late (AdML) promoter initiator (pAdML-Inr-luc), and the human immunodeficiency virus (HIV)-1 initiator (pHIV-1-Inr-luc), the annealed oligonucleotides representing Ϫ22 to ϩ10 of the MIS promoter, Ϫ18 to ϩ33 of the AdML promoter, or Ϫ3 to ϩ42 of the HIV-1 promoter were inserted into the HindIII site of the pA3-luciferase vector, respectively. The constructs, p5Јmut,3Јwt,Ϫ22/ϩ10-luc (for 5Ј mutated, 3Ј wild type) and p5Јwt,3Јmut,Ϫ22/ϩ10-luc were created by replacing the 5Ј or 3Ј 16 nucleotides of the hMIS initiator with unrelated phage sequence (5Ј-TCTATCACCGCAAGGG-3Ј), respectively. An expression construct for the human sex-determining region of the Y chromosome (SRY) was made by inserting the complete open reading frame of human SRY into the BamHI site of the pCMV8 expression vector [45] . The fidelity of all PCRamplified sequences was verified by dideoxyribonucleotide sequencing.
Cell Transfection and Luciferase Assays
The CH34 cells, cloned from the urogenital ridge cells of 14.5-day-old male rat embryos that had been immortalized by ⌿2-v-myc retrovirus infection, were cultured as described elsewhere [46] . For transient transfections, CH34 cells in 9-cm 2 wells were transfected by calcium phosphate precipitation with 2 g of the luciferase reporter vector and 0.5 g of pXGH5 vector [47] directing human growth hormone expression as a control for transfection efficiency. In experiments where SRY is overexpressed, 1 g of pCMV8-SRY expression vector or the parental pCMV8 vector was cotransfected with the luciferase and growth hormone vectors. After 40 to 48 h of incubation, the transfected cells were washed three times with 2 ml of Hanks balanced salt solution, scraped in extraction buffer (100 mM K 2 HPO 4 [pH 7.8], 1 mM dithiothreitol [DTT]), and resuspended in 100 l of extraction buffer. Cells were lysed by three freeze-thaw cycles. Following centrifugation at 15 500 ϫ g for 5 min, luciferase activity was detected in the supernatant by chemiluminescence with luciferin substrate (Promega, Inc., Madison, WI) using a Nichols Institute luminometer (San Juan Capistrano, CA) and expressed as mean Ϯ SD from three to six independent transfections after normalization to growth hormone activity.
Electrophoretic Mobility Shift Assays
The oligonucleotides used in the assays were hMIS initiator Ϫ22/ϩ10, randomized hMIS initiator, terminal deoxynucleotidyl transferase (TdT) initiator [22] , AdML initiator [37] , and Sp1 consensus elements [48] (Table 1 ). The wild-type and mutant T cell receptor-derived variable region ␤-chain gene (V␤) Inr-containing oligonucleotides have been described [49] , as has the E box oligonucleotide [50] . Nuclear extracts from CH34 cells were prepared as described elsewhere [51] . A typical reaction mixture for experiments shown in Figure 2 , A and B, included 5 fmol of 32 P-labeled double-stranded oligonucleotide (ϳ50 000 cpm), 1 g of poly (dI·dC) or poly (dA·dT), 10% glycerol, 10 mM Hepes (pH 7.9), 60 mM KCl, 1 mM DTT, 0.5 g of BSA, and 0.5 to 2 g of nuclear extract in a volume of 20 l. Labeling of the oligonucleotides was accomplished by using either the Klenow fragment of DNA polymerase with [␣-32 P]dATP or T4 polynucleotide kinase with [␥-32 P]ATP. In competition experiments, unlabeled doublestranded oligonucleotides were added to the reaction mixtures at different concentrations before the addition of nuclear extract. After a 30-min incubation at 30ЊC, the samples were loaded onto a 6% polyacrylamide gel in a glycerol-tolerant buffer (90 mM Tris, 30 mM taurine, 0.5
FIG. 1. A)
Alignment of the core promoter regions of the human, bovine, rat, and mouse MIS genes. Gaps were introduced into the sequences of the core promoter regions of the human [17] , bovine [17] , rat [18] , and mouse [63] MIS genes with the Gap program of the University of Wisconsin Genetics Computer Group software [64] . Nucleotides in uppercase letters indicate agreement between at least three of the sequences. Note that the human promoter does not contain a consensus TATA box, whereas the other three promoters do. (The mutations utilized in B, D, and E are shown below the core promoter sequences.) B) The basal transcription of hMIS requires the region containing the transcription start site (Ϫ22 to ϩ10) but not the nonconsensus TATA element. CH34 cells were transiently transfected with pA3-luciferase reporter constructs containing the intact hMIS promoter (Ϫ269/ϩ8, hMIS-luc), or with promoters of approximately the same length in which either the putative Inr element (Ϫ269 hMIS, Inr mut-luc) or the nonconsensus TATA element (Ϫ269 hMIS, TATA mut-luc) were mutated. C) The transcriptional activity conferred by the hMIS initiator compared with other initiator sequences. The hMIS initiator (Ϫ22 to ϩ10, hMIS Inr-luc) was compared to the HIV-1 initiator (Ϫ3 to ϩ42; HIV-1 Inr-luc), the AdML initiator (Ϫ18 to ϩ33; AdML Inr-luc), or the parent reporter (pA3-luc) in COS-1 cells. Luciferase activities (mean Ϯ SD from three to six independent transfection assays) were normalized for transfection efficiency using cotransfected human growth hormone. D) The Ϫ6 to ϩ10 region of the hMIS gene is critical for transcription. The transcriptional activity of the hMIS promoter, in which either the 3Ј (5Јwt, 3Јmut, Ϫ22/ϩ10-luc) or 5Ј-(5Јmut, 3Јwt, Ϫ22/ϩ10-luc) 16 nucleotides were replaced by unrelated phage sequence were compared with those of empty pA3-luciferase vector (pA3-luc) or intact hMIS initiator (hMIS Ϫ22/ϩ10-luc). E) The hMIS initiator allows transcriptional activation by a heterologous enhancer element. The wild-type and mutant hMIS initiator constructs, which contain three SRY-binding sites 5Ј of the Inr elements, were cotransfected with an SRY expression vector (SRY) or with the parental expression vector (CMV) into CH34 cells. Luciferase activities (mean Ϯ SD from three to six independent experiments) were normalized to human growth hormone expression.
FIG. 2. A)
The hMIS initiator forms a specific DNA-protein complex with CH34 nuclear extracts. The EMSAs using the 32 P end-labeled hMIS initiator (Ϫ22 to ϩ10) sequence show binding of CH34 nuclear extracts. Three different unlabeled competitors (hMIS Inr, lanes 3-5; AdML Inr, lanes 6-8; hMIS Inr Mutation [Mut], lanes 9-11) were added at increasing concentrations of 20-, 100-, and 200-fold molar excess, respectively (representative of n ϭ 3). B) Binding of the TdT initiator to HeLa as well as CH34 extracts is competed by the hMIS initiator. The TdT initiator (Ϫ9 to ϩ16) formed a DNAprotein complex with proteins from HeLa cell (lane 2-10) as well as CH34 cell (lanes [12] [13] [14] [15] [16] [17] [18] [19] [20] mM EDTA). For the electrophoretic mobility shift assays (EMSAs) shown in Figures 2C and 3A , reactions were carried out at 4ЊC in volumes of 20 l containing 20 mM Tris (pH 7.9), 0.2 mM EDTA, 5 mM DTT, 0.5 mM PMSF, 10% glycerol, 80 mM KCl, and 100 ng of poly (dA·dT) per reaction as a carrier. The hMIS Inr probe (Ϫ22, ϩ10) had a specific activity of 174 000 cpm/pmol, and 1 pmol was used in Figure 3A , lanes 4-8. The V␤ Inr probe (Ϫ28, ϩ12) had a specific activity of 99 000 cpm/pmol, and 0.017 pmol was used in Figure 3A , lanes 9-14. As competitor probes, the hMIS Inr-containing oligonucleotide was used at 40 pmol per 20 l in Figure 2C , lanes 3 and 4, and 144 pmol per 20 l in Figure 2C , lane 11. When used as a competitor, the V␤ Inr (wild-type and mutant) oligonucleotides were used at 0.689 pmol per 20 l in Figures 2C  and 3A, lanes 6, 7, 12 , and 13. For reactions employing the anti-TFII-I antibody to block complex formation, the antibody was preincubated with the protein source for 10 min at 30ЊC before addition of the labeled probe. DNA-binding reactions proceeded for 20 min at 30ЊC. For reactions exhibiting supershifts, probe and extract were incubated 20 min at 30ЊC, and the antibody was added, followed by 10 min of incubation at 30ЊC. The reactions were electrophoresed through a 5% native gel containing 5% acrylamide and 5% glycerol in 0.5ϫ TBE buffer (45 mM Tris base, 45 mM boric acid, 1 mM EDTA), for 3 h at 140 V. The gel was then dried and subjected to autoradiography.
TFII-I Antisera
Production of the anti-TFII-I antisera has been described elsewhere [27] . For the assays reported in Figures 2C and  3A , the anti-TFII-I antisera was affinity purified [52] .
Recombinant TFII-I
The TFII-I cDNA was cloned according to the method described by Roy et al. [53] . The TFII-I protein was overexpressed as a hexa-histidine fusion protein in bacteria, purified on a Ni 2ϩ -agarose column, and shown to have DNAbinding properties that mirrored those of native TFII-I [53] .
RESULTS
Sequences in the Initiator Region but Not the TATA Region Are Required for Transcription of hMIS
Because the hMIS promoter does not contain a consensus TATA box (CTTAA at Ϫ26 to Ϫ22; Fig. 1A ), we investigated for potential initiator function. Luciferase reporter constructs containing the hMIS promoter (Ϫ269 to ϩ10) with mutations throughout either the potential initiator (Ϫ22 to ϩ10) or the nonconsensus TATA regions (Ϫ28 to Ϫ23; Fig. 1A ) were transiently transfected into CH34 cells, clonally derived from v-myc transformed urogenital ridge cells from 14.5-day-old male embryonic rats and considered to be Sertoli derivatives, because they express MIS (unpublished results) and Sox9 (unpublished results) by Northern blot analysis and/or reverse transcription-PCR. The construct containing mutations in the putative initiator region exhibited only 25% of the transcriptional activity of the wild-type promoter, whereas the construct in which the putative TATA region was mutated exhibited transcriptional activity identical to the wild-type promoter, indicating that the initiator region (Ϫ22 to ϩ10) is essential for the transcription of hMIS and that the nonconsensus TATA element is not functional (Fig. 1B) .
To establish that the putative hMIS Inr element (Ϫ22 to ϩ10) can function as a core promoter, basal transcription conferred by the hMIS initiator was compared to that seen with characterized Inr elements. The hMIS initiator, as well as the previously identified AdML initiator [37] , conferred threefold greater transcriptional activity compared with the empty luciferase vector, suggesting that similar mechanisms operate via these initiation elements, whereas the transcriptional activity of the putative HIV-1 initiator failed to activate basal transcription above the level seen with the luciferase vector alone (Fig. 1C) . The HIV-1 initiator appears to require Rel p50, which may explain its lack of activation in this context [50, 54] .
3Ј 16 Nucleotides in the MIS Initiator Region (Ϫ6 to ϩ10) Are Essential for Transcription of hMIS
To further define the sequences required for core promoter activity, the 5Ј 16 nucleotides (Ϫ22 to Ϫ7) or the 3Ј 16 nucleotides (Ϫ6 to ϩ10) of the hMIS initiator were replaced by an unrelated DNA sequence of the same length from phage (Fig. 1A) . The construct with intact sequence corresponding to nucleotides Ϫ6 to ϩ10 conferred almost the same transcriptional activity as the wild-type hMIS initiator region, whereas the activity of the construct in which nucleotides Ϫ6 to ϩ10 were mutated did not exceed that of the empty vector (Fig. 1D) .
Because the empty luciferase vector contains three SRYbinding sites (5Ј-ATTGTT-3Ј) upstream of the cloning site, we used SRY as a heterologous trans-acting factor to determine whether the hMIS Inr element could function as a core promoter capable of responding to upstream enhancer element activation. Transcription of the construct containing the intact hMIS Ϫ6/ϩ10 sequence, as well as the Ϫ22/ ϩ10 hMIS construct, were induced more than 20-fold by SRY, whereas transactivation of the construct in which the 3Ј region was mutated was almost the same as that of the luciferase vector alone (Fig. 1E) .
hMIS Initiator Forms a Specific DNA-Protein Complex
To elucidate the biochemical interactions occurring via the hMIS initiator, EMSAs done using 32 P-labeled, annealed oligonucleotides corresponding to the hMIS initiator generated one major DNA-protein complex and another minor complex in the presence of nuclear extract from CH34 cells (Fig. 2A, lane 2) . The major complex was subjected to competition by increasing concentrations of unlabeled oligonucleotides corresponding to the hMIS initiator ( Fig.  2A, lanes 3-5) or the AdML initiator ( Fig. 2A, lanes 6-8) , but oligonucleotides corresponding to a mutated hMIS initiator sequence failed to compete for binding to the nuclear extracts ( Fig. 2A, lanes 9-11) or to induce luciferase reporter expression (Fig. 1D) .
Transcription Factor TFII-I Binds to the hMIS Initiator
Because the AdML initiator, which binds to TFII-I from HeLa cell nuclear extract, competed for the factor (or factors) from CH34 cell nuclear extract that bind the hMIS initiator, we studied whether TFII-I could contribute to the complex formed with the hMIS Inr. Because TFII-I was originally purified from HeLa cell nuclear extract and the complex formed between TFII-I and the TdT initiator has been well documented [37] , we used the hMIS initiator in EMSA experiments to compete HeLa cell nuclear protein binding to 32 P-labeled TdT initiator. The major DNA-protein complex formed between the TdT initiator and HeLa nuclear extract (Fig. 2B, lane 2) was competed by unlabeled oligonucleotides corresponding to the hMIS initiator (Fig.  2B, lanes 7 and 8) as well as the TdT (Fig. 2B, lanes 3 and  4) and the AdML initiators (Fig. 2B, lanes 5 and 6) , but not by an unrelated guanine-cytosine-rich oligonucleotide corresponding to the Sp1 consensus element (Fig. 2B, lanes  9 and 10) . The TdT initiator also formed a complex with nuclear extracts from CH34 cells at the same position as the complex formed with HeLa nuclear extracts (Fig. 2B,  lane 12) . This complex was also competed by unlabeled oligonucleotides of TdT, AdML, and hMIS initiators (Fig.  2B, lanes 13-18) , but not by the unrelated Sp1 element (Fig. 2B, lanes 19 and 20) . Thus, a major binding species exists in CH34 and HeLa cell nuclear extracts that recognizes the consensus TdT and AdML Inr elements as well as the hMIS Inr.
To investigate the involvement of the ubiquitously expressed initiator-binding protein TFII-I in the complex with hMIS Inr, EMSA employing highly specific anti-TFII-I antibodies (Fig. 2C ) and competition with a newly described TFII-I-binding initiator from the T cell receptor-derived V␤ Inr was performed [49] . Figure 2C shows that the principal binding activity detected with the hMIS Inr oligonucleotide in the CH34 nuclear extract (lane 2) can be competed with a wild-type Inr (V␤ Inr, lane 3)-containing oligonucleotide, but not with mutant Inr (V␤ Inr mut, lane 4)-containing oligonucleotide, and that it can be blocked with an anti-TFII-I antibody (lane 5) raised to the putative DNA-binding domain of TFII-I [27] . In addition, TFII-I was detected in the complex by supershifting a portion of the complex with the TFII-I antiserum. Antiserum was added after DNA-protein complex formation (1 l of a 1:10 v/v dilution in lane 8, or 1 l undiluted in lane 9), and a supershift of the DNA/ protein complex was observed at the higher concentration of the antibody. In lane 10, 1 l of preimmune serum does not shift the complex. Figure 2C is representative of two separate experiments.
To confirm that TFII-I binds to the hMIS probe, EMSA was performed with highly purified TFII-I [55] . Complex formation observed between purified TFII-I and the hMIS initiator region was observed (Fig. 3A, lanes 2 and 5) , and it was competed with hMIS Inr (Fig. 3A, lane 3) and by a V␤ Inr-containing oligonucleotide (Fig. 3A, lane 6) , but not by a mutant V␤ Inr-containing oligonucleotide (Fig. 3A,  lane 7) . The identity of TFII-I binding was further confirmed using an anti-TFII-I antibody (Fig. 3A, lane 8) . The control reactions in the right panel of Figure 3A demonstrate TFII-I binding to the unrelated V␤ Inr probe. In this case, the labeled V␤ Inr-containing oligonucleotide was competed by hMIS Inr and by the wild-type V␤ Inr-containing oligonucleotides, but not by the mutant V␤ Inr-containing oligonucleotide, suggesting that TFII-I binding is directed through the Inr. Because the binding of TFII-I to the V␤ Inr was much higher (100-fold) compared with that of the hMIS Inr, the unlabeled competitor hMIS (144 pmol)-containing oligonucleotide was present in greater than 200-fold molar excess compared with the unlabeled V␤ (0.689 pmol) competitor in the competition analysis demonstrated in the right panel of Figure 3A .
Further confirmation that TFII-I is the protein binding to the hMIS Inr was demonstrated with bacterially expressed TFII-I (Fig. 3B, lane 2) . The complex can be competed with unlabeled hMIS Inr, V␤ Inr, and to a lesser degree, with an E box-containing oligonucleotide (Fig. 3B, lanes 3, 4, and  6 , respectively). An oligonucleotide containing a mutant V␤ Inr sequence did not compete, showing the specificity of the complex (Fig. 3B, lane 5) .
DISCUSSION
The region of the hMIS gene between Ϫ22 and ϩ10 functioned as an initiator in transient transfection assays with CH34 cells, an MIS-expressing immortalized rat embryonic urogenital ridge-derived cell line. Initiator activity was delimited to the region between Ϫ6 and ϩ10, which appears to be necessary and sufficient for recruitment of preinitiation complexes. Furthermore, mutagenesis of the Inr element, but not the nonconsensus TATA region, inhibited basal promoter activity. Our results strongly suggest that the CTTAA element is nonfunctional, but we cannot completely rule out the possibility that the mutation has substituted an active TATA element with another (unknown) functional element. When incubated with either CH34 cell or HeLa cell nuclear extract, the initiator region (Ϫ22 to ϩ10) formed a specific DNA-protein complex that was inhibited by excess unlabeled MIS initiator DNA as well as by DNA corresponding to the TdT and AdML initiator regions, but not by DNA corresponding to a mutated MIS initiator or to the unrelated SP1-binding element.
Thus, binding in vitro correlates with transcriptional activity in vivo. Antibody-mediated inhibition and supershift demonstrated that this complex contains the initiator-binding protein TFII-I, and that purified TFII-I as well as bacterially expressed TFII-I bound with specificity to the hMIS initiator region.
The control region of a typical regulated eukaryotic gene is comprised of proximal (core) and distal (enhancer) promoter regions. The core promoter region usually consists of one or both of two elements: the TATA box, and the Inr element. In TATA-containing promoters, the initiation of functional transcription involves the ordered assembly of at least six basal transcription factors, including TFIIA, -B, -D, -E, -F, and -H, in addition to RNA polymerase II [29, 56] . TFIID is the only factor known to possess sequencespecific DNA-binding activity and to initiate preinitiation complex assembly through recognition of the TATA box. However, the mechanism of preinitiation complex formation on TATA-less promoters has remained unclear. One postulated model is that a specific initiator-binding protein, such as TFII-I [37] , YY1 [30] , HIP-1 [57] , or USF [58, 59] , with specificity for a certain type of Inr element, binds to that element, recruits TBP, and then recruits the other transcription factors to the preinitiation complex [37] . For example, TFII-I is required for transcription of the promoter containing the AdML initiator [37] . In addition, recent in vitro transcription experiments using the T-cell receptor variable region-derived (V␤) promoter also showed that TFII-I is essential for transcription of this TATA-less initiator-containing promoter, whereas it is dispensable for the TATA element-containing B-cell immunoglobulin heavy chain-derived (immunoglobulin H) promoter [27] . Other initiators that require a precise initiator consensus have been identified that bind a component of TFIID for their function [33] . Several other genes have core promoters that rely on nonconsensus Inr elements [42, 43, 60] . Therefore, it is conceivable that initiator-containing promoters can be divided into several subgroups, with each employing different mechanisms for initiator function; the hMIS promoter uses a TFII-I-binding initiator, suggesting that transcriptional activity of hMIS may be dependent on TFII-I.
Sequence analysis of the hMIS initiator indicated that the sequence Ϫ13 to Ϫ5 (5Ј-CCCAGCCCC-3Ј) rather than the sequence encompassing the transcriptional start site Ϫ2 to ϩ5 (5Ј-GC ϩ1 GCAC-3Ј) was more similar to the pre-A viously reported, pyrimidine-rich initiator consensus YY ϩ1 N(T/A)YY [41] . However, the sequence between A Ϫ14 and ϩ2 did not form a complex with CH34 nuclear protein, whereas the region between Ϫ6 and ϩ10 could form a DNA-protein complex that contained TFII-I. Furthermore, transient transfection assays affirmed that the region between Ϫ6 and ϩ10 was both essential and sufficient for basal transcription of hMIS. These findings are in agreement with those of previous reports that demonstrated the transcriptional start site of the hMIS gene [17, 23] . There are six genes-AdML [37] , TdT [37] , HIV-1 [37] , V␤ [27] , mouse ribonucleotide reductase R1 [61] , and human KDR/ flk-1 [62] -whose promoters are reported to bind to TFII-I, and all fit the initiator consensus sequence, except for HIV-1 and human KDR/flk-1. Here, we have shown that the nonhomologous hMIS initiator can also bind to TFII-I, although TFII-I appears to bind with higher affinity to the TdT, AdML, and V␤ initiators (Fig. 2, A and B) . How TFII-I recognizes both consensus and nonconsensus Inr elements is unclear. Because the optimal binding consensus for TFII-I has not yet been determined experimentally, it remains possible that TFII-I-binding requirements are flexible. Moreover, deduction of the primary amino acid sequence of TFII-I indicated that it is composed of six repeats of putative HLH domains [39] , suggesting the possibility that TFII-I can bind distinct DNA elements and that independent interactions may occur with other distinct HLH proteins [53, 55] . That TFII-I has been shown to bind to E box elements, which bind HLH proteins [50] , and that TFII-I binding to the hMIS Inr was competed less well with an E box-containing oligonucleotide than with the V␤ Inr-containing oligonucleotide (Fig. 3C) is consistent with the possibility that TFII-I has multiple distinct DNA-binding domains.
In EMSA experiments, the observed binding of the hMIS initiator by proteins in CH34 nuclear extracts was also seen using nuclear extracts from HeLa cells (Fig. 2B) and Jurkat T lymphocytes (data not shown). The mobility of the DNA-protein complex formed by the TdT initiator and the hMIS initiators with CH34 nuclear extracts appears to be identical (Fig. 2C) , indicating that the binding proteins in the extracts were neither tissue nor hMIS specific. Consistent with this notion, our data clearly demonstrate binding of a ubiquitous Inr-interacting protein, TFII-I, to the hMIS Inr (Fig. 3) . However, the TdT initiator can bind to TFIID directly [33] , and TAFs play an important role in the basal transcription of TdT by recruiting TBP to the preinitiation complexes [25, 28] . Thus, the TFIID complex containing TAFs, in addition to TFII-I, probably may also be functionally involved in the transcription of hMIS. This is especially true because TFII-I appears to recognizes a component of TFIID for efficient initiator-dependent function [27] .
In summary, the basal transcription of hMIS appears to occur via a nonconsensus novel initiator, and it involves a complex of nuclear proteins that are not tissue specific and that include TFII-I, suggesting that the previously reported empirical initiator consensus sequence is not essential for recognition by TFII-I. Other Inr elements, which are dissimilar from the reported initiator consensus, have been described as well [42, 43, 60] , raising the possibility that TFII-I has a broad specificity of interaction and may recognize multiple Inr elements.
